Canada Pacemaker Market by Type (Implantable v/s External), By Technology (Dual Chamber, Single Chamber, Biventricular Chamber), By Product Type (MRI Compatible v/s Conventional), By Application (Arrythmias, Congestive Heart Failure, Others), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers) and By Region and Competition, Forecast & Opportunities, 2018-2028F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationCanada Pacemaker Market by Type (Implantable v/s External), By Technology (Dual Chamber, Single Chamber, Biventricular Chamber), By Product Type (MRI Compatible v/s Conventional), By Application (Arrythmias, Congestive Heart Failure, Others), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers) and By Region and Competition, Forecast & Opportunities, 2018-2028F
In 2020, 67,399 Canadians died from heart disease or stroke, than from COVID-19 (16,151). Heart disease (53,704) was the second leading cause of death in Canada after cancer, while stroke (13,695) was the fifth leading cause of death.
Growing Aging Population
The growing aging population is a significant driver of the Canada Pacemaker market. As people age, they become more prone to heart conditions such as arrhythmia, bradycardia, and heart block. These conditions can be treated with a pacemaker. Therefore, the increase in the aging population has led to an increase in the prevalence of these heart conditions and a consequent increase in the demand for pacemakers.
Increasing Prevalence of Cardiovascular Diseases
The increasing prevalence of cardiovascular diseases is a significant driver of the Canada Pacemaker market. Cardiovascular diseases are a group of disorders that affect the heart and blood vessels and can lead to various complications such as heart attack, stroke, and heart failure. One of the common treatments for cardiovascular diseases is the use of pacemakers, which regulate the heartbeat and ensure that the heart functions properly.
Download Free Sample ReportTechnological Advancements
Technological advancements are a key driver for the growth of the Canada Pacemaker market. These advancements have led to the development of more advanced and sophisticated pacemakers, which are more efficient and effective in treating heart conditions.
Favorable Government Initiatives
Government initiatives are important drivers of the growth of the Canada Pacemaker market. These initiatives include policies, regulations, and funding programs that promote innovation, research, and development of such medical devices.
Increasing Awareness of the Benefits of Pacemakers
Increasing awareness about pacemakers is a key factor driving the growth of the Canada Pacemaker market.
Recent Development
- MedtronicMicra AVIn 2020, Medtronic launched the Micra AV, the world'ssmallest pacemaker with atrioventricular (AV) synchrony. The device is 70%smaller than traditional pacemakers and is implanted directly into the heartvia a minimally invasive procedure.
- AbbottGallantIn 2019, Abbott launched the Gallant, a new line ofpacemakers that feature Bluetooth connectivity and remote monitoringcapabilities. These devices also have a longer battery life compared toprevious models, lasting up to 14 years.
- BostonScientific AccoladeIn 2018, Boston Scientific launched the Accoladepacemaker, which features a longer battery life and improved pacing options forpatients. The device also includes a technology called HeartLogic, which usessensors to monitor heart failure and alert healthcare providers to potentialissues.
Market Segmentation
Canada Pacemaker market can be segmented by Type, Technology, Product Type, Application, End User, and Region. Based on Type, Canada Pacemaker market can be divided into
Market Players
Medtronic of Canada Ltd, Abbott Medical Canada Inc, Biotronik Canada Inc, LivaNova Canada, Microport Scientific Corp, Spectramedx Inc. are some of the leading players operating in the Canada Pacemaker Market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Type By Technology By Product Type By Application By End User By Region |
| Regional scope | Ontario region; Quebec region; Alberta region; British Columbia region; Saskatchewan and Manitoba region; Rest of Canada |
| Key companies profiled | Medtronic of Canada Ltd, Abbott Medical Canada Inc, Biotronik Canada Inc, LivaNova Canada, Microport Scientific Corp, Spectramedx Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy